Emtricitabine | Australian Register of Therapeutic Goods | Australia | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Emtricitabine
Australia

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Contact Supplier

pharmacompass-2-m-2025-11-03

Emtricitabine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 16 USDMF, 2 JDMF, 12 EU WC, 6 KDMF, 20 NDC API, 17 Listed Suppliers, $ API Reference Price

40 API Suppliers
16 USDMF
2 JDMF
12 EU WC
6 KDMF
20 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

242 Drugs in Development

242 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

250 FDF Dossiers, 60 FDA Orange Book, 85 Europe, 22 Canada, 17 Australia, 53 South Africa, 13 Listed Dossiers

250 FDF Dossiers
60 FDA Orange Book
85 Europe
22 Canada
17 Australia
53 South Africa
13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE, CAPSULE;ORAL - 200MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG
TABLET;ORAL - 150MG;150MG;200MG;300MG
TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE
TABLET;ORAL - 120MG;EQ 15MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE
TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE
TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE
CAPSULE;ORAL - 200MG
TABLET;ORAL - 100MG;150MG
TABLET;ORAL - 133MG;200MG
TABLET;ORAL - 167MG;250MG
TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 10 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 26 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 8 Gangwal Chemicals, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 21 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 27 Controlled & Modified Release, 25 Granulation, 25 Thickeners and Stabilizers, 22 Direct Compression, 19 Disintegrants & Superdisintegrants, 17 Solubilizers, 17 Topical, 15 Lubricants & Glidants, 11 Taste Masking, 11 Parenteral, 11 Film Formers & Plasticizers, 10 Co-Processed Excipients, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 4 Surfactant & Foaming Agents, 4 Vegetarian Capsules

54 Fillers, Diluents & Binders
48 Coating Systems & Additives
27 Controlled & Modified Release
25 Granulation
25 Thickeners and Stabilizers
22 Direct Compression
19 Disintegrants & Superdisintegrants
17 Solubilizers
17 Topical
15 Lubricants & Glidants
11 Taste Masking
11 Parenteral
11 Film Formers & Plasticizers
10 Co-Processed Excipients
9 Empty Capsules
8 Chewable & Orodispersible Aids
6 Emulsifying Agents
5 API Stability Enhancers
5 Coloring Agents
5 Rheology Modifiers
4 Surfactant & Foaming Agents
4 Vegetarian Capsules

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 196 News #PharmaBuzz

3 Data Compilation #PharmaFlow
2 Stock Recap #PipelineProspector
196 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions, 11 Regulatory FDF Prices, 120 Annual Reports

24 US Medicaid Prescriptions
11 Regulatory FDF Prices
120 Annual Reports

MARKET PLACE

8 APIs, 9 FDF Dossiers

8 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

96 US Patents, 9 US Exclusivities, 54 Health Canada Patents

96 US Patents
9 US Exclusivities
54 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 6 Others

4 USP
6 Others

$ API Ref.Price (USD/KG) : 319 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

17 All

01 3Alphapharm Pty Ltd

02 4Arrotex Pharmaceuticals Pty Ltd

03 2Cipla Australia Pty Ltd

04 5Gilead Sciences Pty Limited

05 1Janssen-Cilag Pty Ltd

06 2Sandoz Pty Ltd

filter Active Ingredients Reset all filters

17 All

01 1bictegravir + emtricitabine + tenofovir alafenamide

02 1darunavir + cobicistat + emtricitabine + tenofovir alafenamide

03 1emtricitabine + rilpivirine + tenofovir alafenamide

04 2emtricitabine + tenofovir alafenamide

05 1tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat

06 10tenofovir disoproxil + emtricitabine

07 1tenofovir disoproxil + emtricitabine + efavirenz

filter Dosage Form Reset all filters

17 All

01 13Tablet

02 1Tablet; Tablet; Tablet; Tablet

03 2Tablets

04 1Blank

filter Brand Name Reset all filters

17 All

01 1Biktarvy

02 2CIPLA TENOFOVIR + EMTRICITABINE 300/200

03 2Descovy

04 1Genvoya

05 1Odefsey

06 1Symtuza

07 2TENOFOVIR/EMTRICITABINE 300/200 APX

08 2TENOFOVIR/EMTRICITABINE 300/200 ARX

09 1Tenofovir Disoproxil Emtricitabine Efavirenz

10 2Tenofovir Disoproxil Emtricitabine Viatris 30

11 2Tenofovir/Emtricitabine Sandoz 301/200

List of Suppliers

Product Main Page

01

Alphapharm Pty Ltd

CPhI India

Not Confirmed

Alphapharm Pty Ltd

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

tenofovir disoproxil + emtricitabine

Brand Name : Tenofovir Disoproxil Emtricitabine Viatris 30

Dosage Form : Tablets

Dosage Strength : 300MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Arrotex Pharmaceuticals Pty Ltd

CPhI India

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

tenofovir disoproxil + emtricitabine

Brand Name : TENOFOVIR/EMTRICITABINE 300/200 ARX

Dosage Form : Tablet

Dosage Strength : 300MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Arrotex Pharmaceuticals Pty Ltd

CPhI India

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

tenofovir disoproxil + emtricitabine

Brand Name : TENOFOVIR/EMTRICITABINE 300/200 APX

Dosage Form : Tablet

Dosage Strength : 300MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Arrotex Pharmaceuticals Pty Ltd

CPhI India

Not Confirmed

Arrotex Pharmaceuticals Pty Ltd

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

tenofovir disoproxil + emtricitabine

Brand Name : TENOFOVIR/EMTRICITABINE 300/200 ARX

Dosage Form : Tablet

Dosage Strength : 300MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Cipla Australia Pty Ltd

CPhI India

Not Confirmed

Cipla Australia Pty Ltd

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

tenofovir disoproxil + emtricitabine

Brand Name : CIPLA TENOFOVIR + EMTRICITABINE 300/200

Dosage Form : Tablet

Dosage Strength : 300MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Cipla Australia Pty Ltd

CPhI India

Not Confirmed

Cipla Australia Pty Ltd

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

tenofovir disoproxil + emtricitabine

Brand Name : CIPLA TENOFOVIR + EMTRICITABINE 300/200

Dosage Form : Tablet

Dosage Strength : 300MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Gilead Sciences Pty Limited

CPhI India

Not Confirmed

Gilead Sciences Pty Limited

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

emtricitabine + tenofovir alafenamide

Brand Name : Descovy

Dosage Form :

Dosage Strength :

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Gilead Sciences Pty Limited

CPhI India

Not Confirmed

Gilead Sciences Pty Limited

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

emtricitabine + rilpivirine + tenofovir alafenamide

Brand Name : Odefsey

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Gilead Sciences Pty Limited

CPhI India

Not Confirmed

Gilead Sciences Pty Limited

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

emtricitabine + tenofovir alafenamide

Brand Name : Descovy

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Gilead Sciences Pty Limited

BOS Manchester

Not Confirmed

Gilead Sciences Pty Limited

BOS Manchester

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat

Brand Name : Genvoya

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!